Target intelligence / Profile preview

Hemoglobin subunit (deoxy form) (Hb (deoxyHb))

Target
Hb (deoxyHb)
Molecular classification
Other
01

Overview

Deoxyhemoglobin is the form of hemoglobin in which the iron atom of each heme group is in the ferrous (Fe²⁺) state and is not bound to oxygen. It predominates in venous blood and is responsible for the dark red (bluish) color of deoxygenated blood. Hemoglobin tetramers consist of two alpha and two beta subunits, each containing a heme group able to bind oxygen reversibly[2][6][9]. In the deoxy state (the "tense" or "T" state), the molecule has a lower affinity for oxygen due to a particular quaternary conformation, stabilized by salt bridges and hydrogen bonds that are disrupted during oxygen binding[1][3]. Deoxyhemoglobin plays a central physiological role in transporting oxygen from the lungs to peripheral tissues and facilitating carbon dioxide return. It is not itself a drug target in the typical sense (receptor, enzyme, transporter), though its properties and concentration are relevant in diseases such as sickle cell anemia and hypoxic states[7][9]. Some experimental drugs, such as RSR-13, target deoxyhemoglobin allosterically to increase oxygen release, but generally, it is not considered a classic therapeutic target[5]. The term "deoxyhemoglobin" refers to a conformational state of the hemoglobin protein, not a unique gene or pharmacological receptor, so it is not a canonical therapeutic target.

Other names
Deoxyhemoglobindeoxy-HbdeoxyHbdeoxyhemoglobin Aunligated hemoglobinT state hemoglobin
02

Mechanism of action

Allosteric modulation of oxygen-binding affinity[5] Gas binding/displacement at heme iron

03

Biological functions

Oxygen transportCarbon dioxide transportAcid-base buffering
04

Disease associations

Cardiovascular diseaseSickle cell diseaseAnemiaHypoxia-related disorders
05

Safety considerations

Tissue hypoxiaSickle hemoglobin polymerization leading to vaso-occlusion in sickle cell disease[7]Methemoglobinemia (indirectly, from oxidative stress)
06

Interacting drugs

RSR-13 (efaproxiral)[5]

1 more in the full profile.

07

Biomarkers

Blood oxygen saturation (SpO₂)Deoxyhemoglobin levels in pulse oximetry, MRI, fMRI (BOLD imaging)[6]

Beyond the preview

Go deeper on Hemoglobin subunit (deoxy form) (Hb (deoxyHb)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hemoglobin subunit (deoxy form) (Hb (deoxyHb)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call